Ozempic profits are helping fund a new Nvidia-powered AI supercomputer
The owner of Novo Nordisk, the drugmaker that gave the world Ozempic and Wegovy, is funding a new supercomputer powered by Nvidia’s artificial intelligence technology with a key aim of discovering new medicines and treatments.
